HNX: LDP Statistics

Total Valuation

Lamdong Pharmaceutical JSC has a market cap or net worth of VND 124.49 billion. The enterprise value is 163.37 billion.

Market Cap	124.49B
Enterprise Value	163.37B

Important Dates

The last earnings date was Thursday, January 16, 2025.

Earnings Date	Jan 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Lamdong Pharmaceutical JSC has 12.70 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	n/a
Shares Outstanding	12.70M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	18.87%
Float	12.70M

Valuation Ratios

The trailing PE ratio is 18.28.

PE Ratio	18.28
Forward PE	n/a
PS Ratio	0.57
PB Ratio	1.25
P/TBV Ratio	1.26
P/FCF Ratio	20.52
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.32, with an EV/FCF ratio of 26.93.

EV / Earnings	23.99
EV / Sales	0.75
EV / EBITDA	8.32
EV / EBIT	12.40
EV / FCF	26.93

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.55.

Current Ratio	1.48
Quick Ratio	0.51
Debt / Equity	0.55
Debt / EBITDA	2.80
Debt / FCF	9.07
Interest Coverage	2.65

Financial Efficiency

Return on equity (ROE) is 7.11% and return on invested capital (ROIC) is 5.27%.

Return on Equity (ROE)	7.11%
Return on Assets (ROA)	4.10%
Return on Capital (ROIC)	5.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.08
Inventory Turnover	3.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.50% in the last 52 weeks. The beta is 0.62, so Lamdong Pharmaceutical JSC's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-30.50%
50-Day Moving Average	10,732.00
200-Day Moving Average	16,258.50
Relative Strength Index (RSI)	43.23
Average Volume (20 Days)	17,811

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Lamdong Pharmaceutical JSC had revenue of VND 217.96 billion and earned 6.81 billion in profits. Earnings per share was 536.00.

Revenue	217.96B
Gross Profit	64.39B
Operating Income	13.17B
Pretax Income	6.81B
Net Income	6.81B
EBITDA	19.64B
EBIT	13.17B
Earnings Per Share (EPS)	536.00

Full Income Statement

Balance Sheet

The company has 16.14 billion in cash and 55.03 billion in debt, giving a net cash position of -38.88 billion or -3,060.85 per share.

Cash & Cash Equivalents	16.14B
Total Debt	55.03B
Net Cash	-38.88B
Net Cash Per Share	-3,060.85
Equity (Book Value)	99.18B
Book Value Per Share	7,826.66
Working Capital	50.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.57 billion and capital expenditures -2.50 billion, giving a free cash flow of 6.07 billion.

Operating Cash Flow	8.57B
Capital Expenditures	-2.50B
Free Cash Flow	6.07B
FCF Per Share	477.62

Full Cash Flow Statement

Margins

Gross margin is 29.54%, with operating and profit margins of 6.04% and 3.12%.

Gross Margin	29.54%
Operating Margin	6.04%
Pretax Margin	3.12%
Profit Margin	3.12%
EBITDA Margin	9.01%
EBIT Margin	6.04%
FCF Margin	2.78%

Dividends & Yields

Lamdong Pharmaceutical JSC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	5.47%
FCF Yield	4.87%

Stock Splits

The last stock split was on June 9, 2017. It was a forward split with a ratio of 1.1515.

Last Split Date	Jun 9, 2017
Split Type	Forward
Split Ratio	1.1515

Scores

Lamdong Pharmaceutical JSC has an Altman Z-Score of 2.54. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	n/a